Biopharmaceutical Tubing Market Growth Forecast Through 2030: Market Size And Trends In 2026
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biopharmaceutical Tubing Market Size And Revenue Outlook Through 2030
The biopharmaceutical tubing market has experienced rapid expansion in recent years. Its value is projected to rise from $4.79 billion in 2025 to $5.32 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.2%. This historical growth can be ascribed to the expansion of biopharmaceutical manufacturing capacity, increasing standardization of sterile processing components, early adoption of silicone and PVC tubing in drug production lines, growth in contract manufacturing and fill-finish activities, and a rising regulatory emphasis on material biocompatibility and purity.
The biopharmaceutical tubing market is projected to experience substantial expansion in the coming years. It is anticipated to reach $8.12 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This projected growth during the forecast timeframe is primarily driven by an expanding array of biologics and cell and gene therapy products, a noticeable shift towards single-use and disposable processing solutions, increased need for high-performance TPE and polyolefin tubing, wider implementation of automated production and closed system workflows, and increased funding for advanced bioprocessing and aseptic transfer methods. Key trends anticipated over the forecast period encompass a greater reliance on high-purity and biocompatible tubing within biopharmaceutical processes, the growing acceptance of single-use and sterile transfer tubing systems, an increasing requirement for precise fluid handling in pharmaceutical manufacturing and fill-finish procedures, the broadening of tubing applications across pharmaceutical, medical device, and research & development environments, and a significant emphasis on material longevity, ensuring sterility, and managing contamination.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical Tubing Market Industry Drivers: What’s Behind The Revenue Growth?
The expanding adoption of personalized medicines is anticipated to propel the future growth of the biopharmaceutical tubing market. Personalized medicine describes a medical strategy that customizes healthcare choices, procedures, interventions, and treatments to align with each patient’s individual characteristics. This approach has gained prominence due to genetic research, which facilitates bespoke treatment plans based on an individual’s genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing is instrumental in personalized medicine, offering precise, sterile, and dependable fluid transfer, which is essential for delivering tailored treatments and therapies suited to individual patient profiles. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized therapies in 2023, an increase from 18 in 2022, signifying one of the highest annual increments in personalized medicine approvals. Therefore, the rising number of personalized medicines is a significant factor driving the expansion of the biopharmaceutical tubing market.
Biopharmaceutical Tubing Market Segment Landscape: Which Areas Lead Development?
The biopharmaceutical tubing market covered in this report is segmented –
1) By Product: Silicone Tubing, Polyvinyl Chloride (PVC) Tubing, Polyolefin Tubing, Thermoplastic Elastomer Tubing
2) By Manufacturing Process: Extrusion, Vulcanization, Other Manufacturing Processes
3) By Application: Pharmaceutical, Medical Devices, Research And Development, Other Applications
Subsegments:
1) By Silicone Tubing: Medical-Grade Silicone Tubing, Platinum-Cured Silicone Tubing, Peroxide-Cured Silicone Tubing
2) By Polyvinyl Chloride (Pvc) Tubing: Clear Pvc Tubing, Non-Dehp Pvc Tubing, Soft Pvc Tubing
3) By Polyolefin Tubing: Cross-Linked Polyolefin Tubing, Low-Density Polyethylene Tubing, High-DDensity Polyethylene Tubing
4) By Thermoplastic Elastomer Tubing: Medical-Grade Tpe Tubing, Elastomeric Tpe Tubing, Biocompatible Tpe Tubing
#Biopharmaceutical Tubing Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the biopharmaceutical tubing market are developing advanced customizable solutions, such as bioabsorbable tubing, to elevate performance, improve sterility, and optimize fluid handling for sophisticated biopharmaceutical applications. Bioabsorbable tubing denotes specialized products crafted from materials that progressively break down and are absorbed by the body over time, removing the necessity for removal after application. For example, in September 2023, Zeus Company Inc., an advanced polymer solutions provider from the US, introduced its Absorv XSE-oriented tubing, a next-generation bioabsorbable product made for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to pursue BRS applications beyond coronary artery disease treatment and potentially substitute metallic stents in various procedures. The new tubing offers better uniformity in wall thickness and sizing, which leads to increased efficiency during laser cutting processes, ultimately producing more usable scaffolds.
Biopharmaceutical Tubing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Optinova AB, ESI Ultrapure
View The Full Biopharmaceutical Tubing Market Report:
Biopharmaceutical Tubing Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the biopharmaceutical tubing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
